Quality Issues and Recalls Involving Active Pharmaceutical Ingredients and Health Foods
First written in FY2021. 1 of 2 entries say "Worsened", first in FY2023-Q1. Latest entry: FY2023-Q1.
Muromachi Chemicals moved to the "Worse" side of this theme in 2022, 1 year before the typical company in this theme (2023).
The whole theme swung hardest in 2026: 11 of 57 companies on the "Worse" side.
6 other companies' latest entry also says "Worsened".
- FY2023-Q1WorsenedAnnual report
「In the pharmaceutical industry, further strengthening of control systems and stable supply have increasingly been required in response to recent quality issues.」
The disclosure describes an environment in which further strengthening of control systems and stable supply are required in the pharmaceutical industry in response to quality issues. It does not state that a quality issue occurred at the company. - FY2021First statedAnnual report
「If, with respect to pharmaceuticals for which we supply active pharmaceutical ingredients or conduct development and manufacturing or contract manufacturing, events arise beyond the scope of our quality assurance activities that result in suspension of sales, product recalls or damages, this will affect our operating results and financial position.」
The disclosure indicates the possibility of sales suspensions, product recalls and damages arising from adverse effects, foreign matter contamination, quality assessments or nonconformities.